IL-21 (heterodimeric Fc-fused IL-21) fused to immunoglobulin heavy chain constant region heterodimer (heterodimeric Fc), and pharmaceutical composition comprising same
US-11459367-B2 · Oct 4, 2022 · US
This page is not indexed by search engines while we improve data quality.
Patent family 61301158
This patent family groups 4 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 61301158 |
| Family type | — |
| Earliest priority | Sep 2, 2016 |
| First filing country | US |
| Member publications | 4 |
| Countries | US |
| Representative publication | US11459367B2 — IL-21 (heterodimeric Fc-fused IL-21) fused to immunoglobulin heavy chain constant region heterodimer (heterodimeric Fc), and pharmaceutical composition comprising same |
Representative publication
Best representative member for this family based on priority and filing country.
US11459367B2 — IL-21 (heterodimeric Fc-fused IL-21) fused to immunoglobulin heavy chain constant region heterodimer (heterodimeric Fc), and pharmaceutical composition comprising same (published Oct 4, 2022)
Member publications
Related publications in this family.
Il-21 (heterodimeric fc-fused il-21) fused to immunoglobulin heavy chain constant region heterodimer (heterodimeric fc), and pharmaceutical composition comprising same
US-2020399336-A1 · Dec 24, 2020 · US
IL-21 (heterodimeric Fc-fused IL-21) fused to immunoglobulin heavy chain constant region heterodimer (heterodimeric Fc), and pharmaceutical composition comprising same
US-10800825-B2 · Oct 13, 2020 · US
Il-21 (heterodimeric fc-fused il-21) fused to immunoglobulin heavy chain constant region heterodimer (heterodimeric fc), and pharmaceutical composition comprising same
US-2019218267-A1 · Jul 18, 2019 · US